Top Stories
Mitie's "exceptional" cash flow generation provides strategic options
(Alliance News) - Mitie Group PLC delivered a "strong set of full-year results" with "impressive" headline figures, analysts on Thursday said....
Read more
Upgrades to come as Paragon Banking results beat City hopes
(Alliance News) - Paragon Banking Group PLC on Wednesday "delivered again," analysts said, after its first-half results surpassed expectations....
Read more
WH Smith's thriving travel business offsets high street struggles
(Alliance News) - WH Smith PLC's travel business continues to boom, analysts on Wednesday said, leaving the future of its flagging high street operation open to question. ...
Read more
B&M European Value Retail's backward looking update could "spook" City
(Alliance News) - B&M European Value Retail SA results statement was a "curious" statement that could "spook" investors, an analyst on Wednesday said....
Read more
LondonMetric Property well placed for tenth year of dividend growth
(Alliance News) - LondonMetric Property PLC on Tuesday delivered an "impressive" period of operational growth despite wider sector challenges, analysts on Tuesday said....
Read more
Chemring offers long-term value despite near-term operational issues
(Alliance News) - Chemring Group PLC's medium-term prospects remain "compelling", despite short-term manufacturing issues, analysts on Tuesday said....
Read more
BAT backs outlook, but first half falls short of City expectations
(Alliance News) - British American Tobacco PLC has left itself "a lot to do" in the second half despite expressing confidence on Tuesday that it is on track to deliver...
Read more
Omicron contract win supports bullish case for hVIVO - Stifel
(Alliance News) - hVIVO PLC's contract win "neatly demonstrates the potential" of its new Canary Wharf facility, an analyst on Monday said....
Read more
Hollywood Bowl expected to prioritise investment over share buybacks
(Alliance News) - Analysts see further upside to earnings forecasts at Hollywood Bowl Group PLC after a "slightly better" than expected first half performance....
Read more
Zantac ruling throws a "significant spanner into the works" for GSK
(Alliance News) - An adverse US court ruling regarding GSK PLC's heartburn drug, Zantac, was a "surprise," and will, in the short-term, pour "more uncertainty over the investment case," analysts...
Read more